TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -2 | -12 | -20 | -26 | -32 | -50 | -24 |
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/21/12 16:04 | 3/12/12 | ACUR | Acura Pharmaceuticals, Inc | NY | Health | Drug | Pharmaceutical Preparations | Clemens Peter A | IL | O | SVP,CFO | S | -39 | 3.86 | 0 | -10 | -3 | 382 | D | -25 | 38 | 34 | 9 | 25 | 28 | 29 | 20 | -1 | -6 | -17 | -21 | -50 | -42 |
11/13/07 17:16 | 11/8/07 | ACUR | Acura Pharmaceuticals, Inc | NY | Health | Drug | Pharmaceutical Preparations | Clemens Peter A | IL | O | SVP,CFO | S.m | -311 | 1.17 | 0 | -265 | -6 | 4,451 | D | 72 | 60 | 37 | -45 | -40 | -43 | -26 | -25 | -2 | -18 | -23 | -30 | -14 | -58 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |